CRBU250117C1500
- 0.60
- 0.000.00%
Caribou Biosciences Newsroom
BofA Securities Cuts Price Target on Caribou Biosciences to $11 From $13, Maintains Buy Rating
Caribou Biosciences Analyst Ratings
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Cuts Target Price to $6
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9
HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target
Evercore Maintains Caribou Biosciences(CRBU.US) With Hold Rating, Maintains Target Price $3
Evercore ISI Remains a Hold on Caribou Biosciences (CRBU)
Truist Financial Initiates Caribou Biosciences(CRBU.US) With Buy Rating
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9
Caribou Biosciences (CRBU) Receives a Buy From H.C. Wainwright
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9
Caribou Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target
Caribou Biosciences Analyst Ratings
RBC Capital Reiterates Outperform on Caribou Biosciences, Maintains $14 Price Target
Strategic Focus and Financial Runway Extension Bolster Caribou Biosciences' Buy Rating
Caribou Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target
RBC Cuts Price Target on Caribou Biosciences to $14 From $19, Maintains Outperform, Speculative Risk
Caribou Biosciences Analyst Ratings